Archive: August, 2014

 

 

SeaDragon 2014 Annual Meeting Results and Determinations

The following resolutions were put to shareholders of SeaDragon Limited at its Annual Meeting held yesterday.

Read more about SeaDragon 2014 Annual Meeting Results and Determinations

BioScience Managers Capital Return on Healthcare Fund I Locks in 24.7% IRR for Investors

Leading Australian healthcare fund manager Bioscience Managers has maintained its exceptional performance by returning capital to investors from its Australian Bioscience Fund I at 24.7% annual IRR.

Read more about BioScience Managers Capital Return on Healthcare Fund I Locks in 24.7% IRR for Investors

Rex Bionics awarded major research & development grant by NZ Government

Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces that its Auckland-based subsidiary Rex Bionics Ltd (RBL) has been awarded substantial new grant funding by the New Zealand Government to support the research and development of REX 3, the platform for the Company’s next generation of exoskeletons.

Read more about Rex Bionics awarded major research & development grant by NZ Government

Rex Bionics: Appointment of Crispin Simon as CEO

Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces the appointment of Crispin Simon as Chief Executive Officer.

Read more about Rex Bionics: Appointment of Crispin Simon as CEO

Rex Bionics: Interim Results for six months ended 31 May 2014

Rex Bionics Plc (RXB) (formerly Union MedTech Plc) the AIM-listed developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces its maiden unaudited results for the six months ended 31 May 2014.

Read more about Rex Bionics: Interim Results for six months ended 31 May 2014

SeaDragon Update: Edison Investment Research Releases SeaDragon Update

SeaDragon (NZX:SEA) is Australasia’s largest refiner and blender of high-quality internationally certified concentrated fish oils and fractions, including Omega-3 oils.

Read more about SeaDragon Update: Edison Investment Research Releases SeaDragon Update